| Product NDC: | 49643-348 | 
| Proprietary Name: | Winterfat Pollen | 
| Non Proprietary Name: | Eurotia lanata | 
| Active Ingredient(s): | 1 g/20mL & nbsp; Eurotia lanata | 
| Administration Route(s): | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 49643-348 | 
| Labeler Name: | Allermed Laboratories, Inc. | 
| Product Type: | NON-STANDARDIZED ALLERGENIC | 
| FDA Application Number: | BLA102212 | 
| Marketing Category: | BLA | 
| Start Marketing Date: | 19740312 | 
| Package NDC: | 49643-348-05 | 
| Package Description: | 5 mL in 1 VIAL, MULTI-DOSE (49643-348-05) | 
| NDC Code | 49643-348-05 | 
| Proprietary Name | Winterfat Pollen | 
| Package Description | 5 mL in 1 VIAL, MULTI-DOSE (49643-348-05) | 
| Product NDC | 49643-348 | 
| Product Type Name | NON-STANDARDIZED ALLERGENIC | 
| Non Proprietary Name | Eurotia lanata | 
| Dosage Form Name | INJECTION | 
| Route Name | CUTANEOUS; INTRADERMAL; SUBCUTANEOUS | 
| Start Marketing Date | 19740312 | 
| Marketing Category Name | BLA | 
| Labeler Name | Allermed Laboratories, Inc. | 
| Substance Name | KRASCHENINNIKOVIA LANATA POLLEN | 
| Strength Number | 1 | 
| Strength Unit | g/20mL | 
| Pharmaceutical Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |